Ident. | Authors (with country if any) | Title |
---|
001709 |
Robert J. Norman [Australie] ; Fernando Zegers-Hochschild [Chili] ; Bruno S. Salle [France] ; Jolanda Elbers [Pays-Bas] ; Esther Heijnen [Pays-Bas] ; Maya Marintcheva-Petrova [Pays-Bas] ; Bernadette Mannaerts [Pays-Bas] | Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity |
001760 |
MING QIAO [Australie, France, Thaïlande] ; David Shaw ; Remi Forrat ; Anh Wartel-Tram ; Jean Lang | Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans |
001A05 |
Pierre Van Damme [Belgique] ; Peter Mcintyre [Australie] ; Emmanuel Grimprel [France] ; Sherine Kuriyakose [Inde] ; Jeanne-Marie Jacquet [Belgique] ; Karin Hardt [Belgique] ; Marc Messier [Belgique] ; Olivier Van Der Meeren [Belgique] | Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix®) in adults 55 years of age and over: A sub-analysis of four trials |
002348 |
F. M. Russell [Australie] ; J. R. Carapetis [Australie] ; A. Balloch [Australie] ; P. V. Licciardi [Australie] ; A. W. J. Jenney [Australie] ; L. Tikoduadua [Fidji] ; L. Waqatakirewa [Fidji] ; J. Pryor [Fidji] ; J. Nelson [Australie] ; G. B. Byrnes [France] ; Y. B. Cheung [Singapour] ; M. L. K. Tang [Australie] ; E. K. Mulholland [Australie, Royaume-Uni] | Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial |
002A69 |
F. M. Russell [Australie] ; A. Balloch [Australie] ; M. L. K. Tang [Australie] ; J. R. Carapetis [Australie] ; P. Licciardi [Australie] ; J. Nelson [Australie] ; A. W. J. Jenney [Australie] ; L. Tikoduadua [Fidji] ; L. Waqatakirewa [Fidji] ; J. Pryor [Fidji] ; G. B. Byrnes [France] ; Y. B. Cheung [Singapour] ; E. K. Mulholland [Australie, Royaume-Uni] | Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine |
003132 |
Janet E. Mcelhaney [États-Unis, Canada] ; Jan P. Dutz [Canada] ; David Holland [Nouvelle-Zélande] ; Robert Booy [Australie] ; Ferdinandus De Looze [Australie] ; Peter Eizenberg [Australie] ; James Mcdonald [Australie] ; Jeff Karrasch [Australie] ; Maureen Mckeirnan [Australie] ; Hatem Salem [Australie] ; Graham Mills [Nouvelle-Zélande] ; Jim Reid [Nouvelle-Zélande] ; Francoise Weber [France] ; Melanie Saville [France] | Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults : A Randomized Controlled Trial. Commentary |
003D13 |
J. M. Jacquet [Belgique] ; P. Begue [France] ; E. Grimprel [France] ; P. Reinert [France] ; S. Sandbu [Norvège] ; S. A. Silfverdal [Suède] ; G. Faldella [Italie] ; T. Nolan [Australie] ; S. Lambert [Australie] ; P. Richmond [Australie] ; H. Marshall [Australie] ; D. Roberton [Australie] ; L. Schuerman [Belgique] | Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age : A review |
003F63 |
Scott Kitchener [Australie] ; Michael Nissen [Australie] ; Peter Nasveld [Australie] ; Remi Forrat [France] ; Sutee Yoksan [Thaïlande] ; Jean Lang [France] ; Jean-Francois Saluzzo [France] | Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults |
005A60 |
David E. Briles [États-Unis] ; Susan K. Hollingshead [États-Unis] ; Gary S. Nabors [États-Unis] ; James C. Paton [Australie] ; Alexis Brooks-Walter [États-Unis] | The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae |
006304 |
C. F. Ockenhouse [États-Unis, Royaume-Uni, France, Australie, Japon] ; P.-F. Sun ; D. E. Lanar ; B. T. Wellde ; B. T. Hall ; K. Kester ; J. A. Stoute ; A. Magill ; U. Krzych ; L. Farley ; R. A. Wirtz ; J. C. Sadoff ; D. C. Kaslow ; S. Kumar ; L. W. P. Church ; J. M. Crutcher ; B. Wizel ; S. Hoffman ; A. Lalvani ; A. V. S. Hill ; J. A. Tine ; K. P. Guito ; C. De Taisne ; R. Anders ; T. Horii ; E. Paoletti ; W. R. Ballou | Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria |
006336 |
R. Khanna [Australie] ; P. Busson [France] ; S. R. Burrows [Australie] ; C. Raffoux [France] ; D. J. Moss [Australie] ; J. M. Nicholls [Hong Kong] ; L. Cooper [Australie] | Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): Evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells |
006460 |
C. A. White [Australie] ; S. A. Thomson [Australie] ; L. Cooper [Australie] ; P. M. Van Endert [France] ; R. Tampe [Allemagne] ; B. Coupar [Australie] ; L. Qiu [Australie] ; P. G. Parsons [Australie] ; D. J. Moss [Australie] ; R. Khanna [Australie] | Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells |